We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Law Firm Seeks to Reopen Fraud Case Against Allergan Subsidiary
Law Firm Seeks to Reopen Fraud Case Against Allergan Subsidiary
A Washington, D.C. law firm petitioned the U.S. Attorney’s Office in Boston to reopen an investigation of Forest Laboratories, claiming the company misrepresented clinical trial results used as the basis for Lexapro’s approval for pediatric use.